China Pharma Holdings CPHI
NYSE CPHI
$1.03 -0.05 (-4.63%)
At close: Aug 20, 2026 · 11:55 AM UTC

China Pharma Holdings (CPHI) Income from Non-Controlling Interests (2012 - 2015)

China Pharma Holdings' (CPHI) quarterly Income from Non-Controlling Interests came in at $1.4 million in Q2 2015, up 116.33% YoY from $640928.2 in Q2 2014, and up 116.33% on a QoQ basis from -$8.5 million in Q2 2014.

China Pharma Holdings (CPHI) Income from Non-Controlling Interests (2012 - 2015) Analysis & Trends

China Pharma Holdings (CPHI) has 4 years of Income from Non-Controlling Interests data on file, last reported at $1.4 million in Q2 2015.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Haleon 44.07 Bn 43.10 Bn - -
2 Teva Pharmaceutical Industries 43.41 Bn 39.75 Bn 2.15 Bn -
3 Zoetis 31.83 Bn 30.15 Bn 1.05 Bn -
4 Takeda Pharmaceutical 28.77 Bn 22.97 Bn 5.10 Bn 376,434.15
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn -
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn -
8 Elanco Animal Health 11.93 Bn 11.40 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.16 Bn 10.00 Bn - -
10 China Pharma Holdings 41.74 Mn 41.43 Mn 83,566.00 -

Historic Data

Download Data
DateValue
Jun 30, 2015 1.39 Mn
Jun 30, 2014 -8.49 Mn
Sep 30, 2013 -1.42 Mn
Sep 30, 2012 1.17 Mn